Advertising Cannabis in the UK: What's Allowed?

UK Rules on Advertising Cannabis Products
The advertising of cannabis products in the UK is strictly regulated by a combination of laws and industry codes of practice. Understanding these rules is essential for any business operating in the medical cannabis sector, as breaching advertising regulations can result in significant penalties, reputational damage, and enforcement action from regulatory bodies.

The Advertising Standards Authority and CAP Code
The Advertising Standards Authority (ASA) and the Committee of Advertising Practice (CAP) are the primary bodies governing advertising standards in the UK. The CAP Code is a set of rules that all advertisers must follow, covering all forms of advertising including digital, broadcast, print, and outdoor media.

For cannabis-related products, the CAP Code is particularly stringent. Advertisements must not promote the use of cannabis products in ways that could encourage irresponsible consumption. The ASA takes a cautious approach to cannabis advertising, scrutinising claims carefully to ensure they are not misleading or potentially harmful to consumers.

Any advertiser promoting cannabis products must ensure their messaging complies with CAP Code rules, particularly those relating to substantiation of claims, harm prevention, and protection of vulnerable audiences.

Medical Claims and CBD Products

One of the most important restrictions affecting UK cannabis businesses relates to making medical claims. Under UK law, any product that makes a medical claim is classified as a medicine and must be licensed by the Medicines and Healthcare products Regulatory Agency (MHRA).

This means that CBD products and other cannabis-derived products cannot legally claim to treat, cure, prevent, or manage any medical condition unless they have obtained a medicines licence from the MHRA. Currently, very few CBD products hold such licenses in the UK, making medical claims effectively prohibited for the vast majority of products on the market.

Companies cannot state that their products treat conditions such as anxiety, chronic pain, epilepsy, or any other health complaint. Statements like “CBD for anxiety,” “cannabis relieves pain,” or “helps manage PTSD” are all prohibited and could result in enforcement action.

Advertisers must be extremely careful with their language, avoiding even indirect medical claims. Phrases that suggest therapeutic benefits, such as “promotes wellness” or “supports mental health,” can also be problematic if they imply treatment of a medical condition.

Social Media Restrictions

Social media advertising of cannabis products faces particular restrictions in the UK. Most major platforms, including Facebook, Instagram, and TikTok, have their own policies that either prohibit or severely restrict cannabis product advertising.

Additionally, under the CAP Code and BCAP (Broadcast Committee of Advertising Practice) rules, advertising must not be targeted at individuals under 18 years old. For cannabis products, this is taken very seriously, and any advertising risks being challenged if it appears to target younger audiences or could easily be accessed by minors.

Organic social media content (non-paid posts) is also subject to ASA jurisdiction. Influencers and companies posting about cannabis products must ensure they comply with advertising standards, even when content is not directly sponsored.

What Companies Can Say

While restrictions are stringent, cannabis companies can still advertise their products legally if they follow guidelines carefully. Permitted statements typically focus on factual information about the product itself.

Companies can describe what their product contains, such as “full-spectrum CBD oil” or “THC-free hemp extract.” They can provide information about dosage, ingredients, and usage instructions. However, any information must be accurate and substantiated.

For licensed medicines, companies can make the claims authorised on the product licence. Educational content about cannabis, the endocannabinoid system, or general wellness information may be permissible if it doesn’t cross into making medical claims about specific products.

Testimonials and reviews present a grey area. While companies cannot make medical claims themselves, user testimonials that happen to mention health benefits are sometimes permitted, though the ASA scrutinises these carefully.

Compliance and Enforcement

Non-compliance with advertising regulations can result in ASA adjudications, which are published and damage brand reputation. The MHRA may also take enforcement action if products are being marketed as medicines without proper licensing.

Any company advertising cannabis products in the UK should seek legal advice, maintain detailed records of all advertising claims, and ensure all content is reviewed against current regulations before publication.

Advertising Cannabis in the UK: What’s Allowed?

Medical Claims and CBD Products

Social Media Restrictions

What Companies Can Say

Compliance and Enforcement

Further Reading